Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1951 AL 1965

Genetics of Parkinson's disease

Cherian A, Divya KP.

Acta Neurol Belg. 2020 Dec;120(6):1297-1305. doi: 10.1007/s13760-020-01473-5. Epub 2020 Aug 19.

Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review

Cooray R, Gupta V, Suphioglu C.

Mol Neurobiol. 2020 Nov;57(11):4878-4890. doi: 10.1007/s12035-020-02054-6. Epub 2020 Aug 19.

Dopamine receptors in emesis: Molecular mechanisms and potential therapeutic function

Belkacemi L, Darmani NA.

Pharmacol Res. 2020 Nov;161:105124. doi: 10.1016/j.phrs.2020.105124. Epub 2020 Aug 16.

Neuropathological findings in PINK1-associated Parkinson's disease

Nybø CJ, Gustavsson EK, Farrer MJ, Aasly JO.

Parkinsonism Relat Disord. 2020 Sep;78:105-108. doi: 10.1016/j.parkreldis.2020.07.023. Epub 2020 Aug 9.

Association between a DJ-1 polymorphism and the risk of Parkinson's disease: a PRISMA-compliant systematic review and meta-analysis

Liu J, Li C, Zhou X, Sun J, Zhu M, Zhang H, Cheng L, Li G, He T, Deng W.

J Int Med Res. 2020 Aug;48(8):300060520947943. doi: 10.1177/0300060520947943.

Coronavirus Disease 2019 and Parkinsonism: A Non-post-encephalitic Case

Faber I, Brandão PRP, Menegatti F, de Carvalho Bispo DD, Maluf FB, Cardoso F.

Mov Disord. 2020 Oct;35(10):1721-1722. doi: 10.1002/mds.28277. Epub 2020 Sep 24.

Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future Opportunities

Olanow CW, Calabresi P, Obeso JA.

Mov Disord. 2020 Oct;35(10):1731-1744. doi: 10.1002/mds.28215. Epub 2020 Aug 20.

Toward biomarker-based clinical subtyping of Parkinson disease

Lamotte G, Becker B.

Neurology. 2020 Sep 15;95(11):461-462. doi: 10.1212/WNL.0000000000010496. Epub 2020 Aug 14.

Iron-responsive-like elements and neurodegenerative ferroptosis

Rogers JT, Cahill CM.

Learn Mem. 2020 Aug 17;27(9):395-413. doi: 10.1101/lm.052282.120. Print 2020 Sep.

Pharmacological profile of natural and synthetic compounds with rigid adamantane-based scaffolds as potential agents for the treatment of neurodegenerative diseases

Dembitsky VM, Gloriozova TA, Poroikov VV.

Biochem Biophys Res Commun. 2020 Sep 3;529(4):1225-1241. doi: 10.1016/j.bbrc.2020.06.123. Epub 2020 Aug 7.

Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia

Lesman-Segev OH, Edwards L, Rabinovici GD.

Semin Neurol. 2020 Aug;40(4):394-410. doi: 10.1055/s-0040-1715134. Epub 2020 Aug 20.

Helicobacter pylori infection: Beyond gastric manifestations

Santos MLC, de Brito BB, da Silva FAF, Sampaio MM, Marques HS, Oliveira E Silva N, de Magalhães Queiroz DM, de Melo FF.

World J Gastroenterol. 2020 Jul 28;26(28):4076-4093. doi: 10.3748/wjg.v26.i28.4076.

Potential Role of Natural Polyphenols against Protein Aggregation Toxicity: In Vitro, In Vivo, and Clinical Studies

Henríquez G, Gomez A, Guerrero E, Narayan M.

ACS Chem Neurosci. 2020 Oct 7;11(19):2915-2934. doi: 10.1021/acschemneuro.0c00381. Epub 2020 Sep 11.

Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria

Martí-Andrés G, van Bommel L, Meles SK, Riverol M, Valentí R, Kogan RV, Renken RJ, Gurvits V, van Laar T, Pagani M, Prieto E, Luquin MR, Leenders KL, Arbizu J.

Mov Disord. 2020 Nov;35(11):2009-2018. doi: 10.1002/mds.28217. Epub 2020 Aug 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias